Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 135

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 135
---
 third-party service providers. The actions that we are taking are subject to ongoing executive
management review. If we are unable to successfully remediate the material weakness, or if in the future, we identify further material
weaknesses in our internal controls over financial reporting, we may not detect errors on a timely basis, and our financial statements
may be materially misstated. We may not be able to conclude on an ongoing basis that we have effective internal control over financial
reporting, which could harm our operating results, cause investors to lose confidence in our reported financial information and cause
the trading price of our stock to fall. In addition, as a public company, we will be required to file accurate and timely quarterly and
annual reports with the SEC under the Exchange Act. Any failure to report our financial results on an accurate and timely basis could
result in sanctions, lawsuits, delisting of our shares from Nasdaq or other adverse consequences that would materially harm our business.
In addition, we could become subject to investigations by Nasdaq, the SEC, and other regulatory authorities, and become subject to litigation
from investors and stockholders, which could harm our reputation and our financial condition, or divert financial and management resources
from our core business.

Neither Longevity’s
or the Target’s management nor an independent registered public accounting firm has performed an evaluation of our internal control
over financial reporting in accordance with the provision of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, because
no such evaluation has been required. Had we or our independent registered public accounting firm performed an evaluation of Longevity’s
and the Target’s internal control over financial reporting in accordance with the provisions of the Sarbanes-Oxley Act, additional
material weaknesses may have been identified.

We may need to raise additional
capital to fund our currently planned operations and achieve our goals. If we are unable to raise additional capital when needed on acceptable
terms or generate cash flows necessary to maintain or expand our operations, we may not be able to compete successfully, which would harm
our business, results of operations, and financial condition.

We may consider
raising additional capital in the future to expand our business, to pursue strategic investments or acquisitions, to take advantage of
favorable market conditions or financing opportunities or for other reasons, even if we believe we have sufficient funds for our current
or future operating plans.

Our future capital requirements will
depend on many factors, including, but